1.
Karthickeyan K, Saara A, Gopal K, Karthick S, Ashi A. A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. JESM [Internet]. 2023Sep.13 [cited 2024Nov.21];2(3):73-9. Available from: https://journals.tma.uz/index.php/jesm/article/view/583